Merck’s at-home antiviral COVID-19 pill approved by US regulator
3 years ago

Merck’s at-home antiviral COVID-19 pill approved by US regulator

Al Jazeera  

United States health regulators have authorised a second antiviral pill against COVID-19, providing another easy-to-use medication to battle the rising tide of Omicron infections. Additionally, Pfizer’s drug was roughly three times more effective in testing than Merck’s, reducing hospitalisation and death by nearly 90 percent among high-risk patients. Merck’s drug is not authorised for use in patients younger than 18 because molnupiravir may affect bone and cartilage growth, the FDA said. “To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.” Dr Nick Kartsonis, Merck’s senior vice president of clinical research, said the company’s scientists are still studying the drug and they hope to eventually get it approved for use in children.

Drug Fda Merck Omicron Pfizer Pill Molnupiravir  pfizer  fda  covid19  approved  drug  molnupiravir  antiviral  merck  athome  regulator  virus  pill  mercks  authorised

History of this topic

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use
1 year, 6 months ago

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use

Associated Press  

WASHINGTON — Pfizer received full approval on Thursday for its COVID-19 pill Paxlovid that’s been the go-to treatment against the coronavirus. The FDA granted full approval for adults with COVID-19 who face high risks of severe disease, which can lead to hospitalization or death. Paxlovid is the fourth drug for COVID-19 to receive full FDA approval and the first one …

European committee: Regulators should deny Merck’s Lagevrio
1 year, 10 months ago

European committee: Regulators should deny Merck’s Lagevrio

Associated Press  

A European medical committee recommends rejection of Merck’s COVID-19 treatment, Lagevrio, casting fresh doubt on a pill that also stirs concern among U.S. regulators. A statement from the agency says a committee that has been reviewing Merck’s application for more than a year concluded that the drug’s clinical benefit could not be demonstrated. Merck said in a statement that it …

Frustration is rising over Covid drug shortages in China, and there are no easy answers
1 year, 11 months ago

Frustration is rising over Covid drug shortages in China, and there are no easy answers

CNN  

Editor’s Note: Editor’s Note: A version of this story appeared in CNN’s Meanwhile in China newsletter, a three-times-a-week update exploring what you need to know about the country’s rise and how it impacts the world. On Monday, Pfizer’s CEO Albert Bourla said the company had ramped up exports, sending millions of courses of Paxlovid to China in the past couple …

Pfizer says its COVID pill doesn’t work for healthier patients
2 years, 6 months ago

Pfizer says its COVID pill doesn’t work for healthier patients

LA Times  

Pfizer says it will focus its efforts on studying its COVID drug, Paxlovid, in vulnerable populations, including people who are immunocompromised or already in the hospital. Pfizer Inc. plans to stop enrollment in a study of its COVID-19 drug in patients who aren’t at high risk of severe disease after the pill didn’t help alleviate their symptoms, a major setback …

COVID-19 pills could be a game-changer, but doctors trying to use them face hurdles
2 years, 9 months ago

COVID-19 pills could be a game-changer, but doctors trying to use them face hurdles

LA Times  

Jeff Carlson, a Type 1 diabetic with heart stents, came down with COVID-19 in January, but recovered quickly after being treated with Merck’s molnupiravir. With vaccines and treatments available, “we can make this much more manageable in the future, if people are willing to take care of themselves,” said Dr. Bryan Jarabek, who helps lead COVID-19 treatment and vaccination efforts …

Covid-19 pill competing with Pfizer’s looks for quick approval in Japan
2 years, 10 months ago

Covid-19 pill competing with Pfizer’s looks for quick approval in Japan

Live Mint  

TOKYO : Drugmaker Shionogi & Co. said it plans to seek approval this month to sell its Covid-19 treatment pill in Japan after the company found that in human trials the pill had strong virus-fighting ability compared with Pfizer Inc.’s Paxlovid. Pfizer said its final-stage trial, which included more than 2,000 patients, showed Paxlovid cut the risk of hospitalization or …

Generic Drugmakers to Make Cheap Versions of Merck's Covid-19 Pill Molnupiravir for Poorer Nations
2 years, 11 months ago

Generic Drugmakers to Make Cheap Versions of Merck's Covid-19 Pill Molnupiravir for Poorer Nations

News 18  

A UN-backed agency has struck a deal for nearly 30 generic drugmakers to make low-cost versions of Merck & Co’s Covid-19 pill molnupiravir for poorer nations, widening access to a drug seen as a weapon in fighting the pandemic. A molnupiravir course of 40 pills for five days is expected to cost about $20 in poorer nations, an MPP official …

Cheap version of Merck Covid pill to be made for poorer nations
2 years, 11 months ago

Cheap version of Merck Covid pill to be made for poorer nations

India Today  

A UN-backed agency has struck a deal for nearly 30 generic drugmakers to make low-cost versions of Merck & Co's Covid-19 pill molnupiravir for poorer nations, widening access to a drug seen as a weapon in fighting the pandemic. The agreement, negotiated by the UN-backed Medicines Patent Pool with Merck, allows 27 generic drugmakers from India, China and other countries …

New Covid-19 pills carry risks: What patients should know
2 years, 11 months ago

New Covid-19 pills carry risks: What patients should know

Live Mint  

The first Covid-19 antiviral pills that can be taken at home are a new treatment option for infected people, but they carry safety warnings and limitations that could complicate treatment decisions for patients, doctors and pharmacists. In December, the Food and Drug Administration authorized the use of new pills from Merck & Co., with its partner Ridgeback Biotherapeutics, and Pfizer …

New easy-to-use Covid-19 pills come with a catch. Here's how
2 years, 11 months ago

New easy-to-use Covid-19 pills come with a catch. Here's how

India TV News  

Newly infected COVID-19 patients have two new treatment options that can be taken at home. The pills are intended for those with mild or moderate COVID-19 who are more likely to become seriously ill. That includes older people and those with other health conditions like heart disease, cancer or diabetes that make them more vulnerable. Antiviral pills aren't authorized for …

Live updates: Japan approves use of Merck's COVID-19 pill
3 years ago

Live updates: Japan approves use of Merck's COVID-19 pill

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy TOKYO — Japan has approved …

US adds Merck pill as 2nd easy-to-use drug against COVID-19
3 years ago

US adds Merck pill as 2nd easy-to-use drug against COVID-19

Associated Press  

WASHINGTON — U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections. The FDA authorized Merck’s drug for adults with a positive COVID-19 test, early symptoms and who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. Additionally, …

US adds Merck pill as 2nd easy-to-use drug against Covid-19
3 years ago

US adds Merck pill as 2nd easy-to-use drug against Covid-19

India Today  

US health regulators on Thursday authorised the second pill against Covid-19, providing another easy-to-use medication to battle the rising tide of omicron infections. The Food and Drug Administration authorized Merck's drug for adults with early symptoms of Covid-19 who face the highest risks of hospitalisation, including older people and those with conditions like obesity and heart disease. Additionally, Pfizer's drug …

U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19
3 years ago

U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19

LA Times  

U.S. regulators have authorized a second pill against COVID-19: molnupiravir, an antiviral drug from Merck that may help blunt the wave of coronavirus infections. The Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions such as obesity and heart disease. Additionally, …

France scraps order for Merck's Covid antiviral drug after disappointing trial results
3 years ago

France scraps order for Merck's Covid antiviral drug after disappointing trial results

India Today  

France has cancelled its order for Merck & Co's Covid-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer's competing drug before the end of January, the health minister said on Wednesday. France is the first country to publicly say it has cancelled an order for the Merck treatment after the company released data in late November …

Pfizer Pill Becomes First US-authorized Home Covid-19 Treatment
3 years ago

Pfizer Pill Becomes First US-authorized Home Covid-19 Treatment

News 18  

U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus. The long-awaited milestone comes as U.S. cases, hospitalizations and deaths are all rising and health officials warn of a tsunami of new infections from the omicron variant that …

Pfizer pill becomes 1st U.S.-authorized home COVID treatment
3 years ago

Pfizer pill becomes 1st U.S.-authorized home COVID treatment

LA Times  

Americans will be able to take a pill by Pfizer at home to head off the worst effects of the coronavirus. U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the coronavirus. But Pfizer’s drug is all but certain …

Merck's Covid-19 pill Molnupiravir found to reduce hospitalisation, death risks
3 years ago

Merck's Covid-19 pill Molnupiravir found to reduce hospitalisation, death risks

India Today  

As Covid-19 cases peak across the world including the US and the UK, Molnupiravir, an oral drug developed by Merck, could act as a counter. In the phase-III clinical trials, the drug was found to reduce the risk of hospitalisation and death in at-risk, unvaccinated adults, Molnupiravir is an oral, small-molecule antiviral prodrug that is active against severe acute respiratory …

Pfizer confirms COVID pill’s results, potency versus omicron
3 years ago

Pfizer confirms COVID pill’s results, potency versus omicron

Associated Press  

WASHINGTON — Pfizer said Tuesday that its experimental pill to treat COVID-19 appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill’s promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89% among high-risk adults when taken shortly after initial COVID-19 symptoms. The Food and …

Pfizer confirms COVID pill’s results, potency versus Omicron
3 years ago

Pfizer confirms COVID pill’s results, potency versus Omicron

The Hindu  

Pfizer said on Tuesday that its experimental COVID-19 pill appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill’s promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89% among high-risk adults when taken shortly after initial COVID-19 symptoms. The Food and Drug Administration is …

Pfizer says its COVID pill near 90% effective in clinical trials
3 years ago

Pfizer says its COVID pill near 90% effective in clinical trials

Al Jazeera  

The company says it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million in 2022. Pfizer Inc has said the final analysis of its antiviral COVID-19 pill showed close to 90 percent efficacy in preventing hospitalisations and deaths in high-risk patients with recent lab data suggesting the drug retains its effectiveness …

Pfizer confirms Covid pill's potency against Omicron variant
3 years ago

Pfizer confirms Covid pill's potency against Omicron variant

India Today  

Pfizer said Tuesday that its experimental Covid-19 pill appears effective against the Omicron variant. The company also said full results of its 2,250-person study confirmed the pill's promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89 per cent among high-risk adults when taken shortly after initial Covid-19 symptoms. The Food and Drug Administration …

Pfizer and Merck covid-19 pills are coming soon in the US, but other countries will have to wait
3 years ago

Pfizer and Merck covid-19 pills are coming soon in the US, but other countries will have to wait

Live Mint  

Promising Covid-19 treatment pills are likely to take longer to reach patients in low- and middle-income countries than in rich ones because of manufacturing and pricing obstacles, despite efforts by drugmakers to make them more available, drug-access advocates and public-health experts say. Yet drug-access advocates and public-health experts express concern that the pills will arrive months later in poor countries …

UK planning to rollout Merck's anti-Covid pill as soon as Christmas: Report
3 years ago

UK planning to rollout Merck's anti-Covid pill as soon as Christmas: Report

Hindustan Times  

The government in the United Kingdom is planning to roll out the antiviral pill against Coronavirus disease as part of an offered treatment against the viral disease, according to a report by Sunday Telegraph. The pill -- Molnupiravir -- has been developed by American pharmaceutical company Merck and has been touted as "game-changing" as it can be taken from the …

Merck’s covid-19 pill backed by FDA advisers
3 years ago

Merck’s covid-19 pill backed by FDA advisers

Live Mint  

An outside panel of scientific advisers to the Food and Drug Administration narrowly recommended the agency authorize the experimental Covid-19 oral antiviral from Merck & Co. and partner Ridgeback Biotherapeutics LP. Several panel members who voted in favor of authorization said use of molnupiravir should be limited to unvaccinated people at high risk of Covid-19 complications, and that while more …

US panel backs first-of-a-kind COVID-19 pill from Merck
3 years ago

US panel backs first-of-a-kind COVID-19 pill from Merck

Associated Press  

WASHINGTON — A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus. The Food and Drug Administration panel voted 13-10 that the antiviral drug’s benefits outweigh its risks, including potential birth defects …

US panel backs Merck's first-of-a-kind Covid-19 pill
3 years ago

US panel backs Merck's first-of-a-kind Covid-19 pill

Hindustan Times  

A panel of US health advisers on Tuesday narrowly backed a closely watched Covid-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus. A Food and Drug Administration panel voted 13-10 that the drug’s benefits outweigh its risks, including potential birth defects if used during …

US health panel endorses Merck’s COVID-19 pill
3 years ago

US health panel endorses Merck’s COVID-19 pill

Al Jazeera  

If the FDA authorises the drug, it would be the first at-home treatment for COVID-19 two years into the pandemic. He said FDA would have to carefully tailor the drug’s use for patients who stand to benefit most. If the FDA authorises the drug, it would be the first at-home treatment for the virus nearly two years into the pandemic. …

Merck’s covid-19 pill to be reviewed by FDA advisers
3 years ago

Merck’s covid-19 pill to be reviewed by FDA advisers

Live Mint  

An outside panel of scientific advisers to the Food and Drug Administration is scheduled to meet Tuesday to discuss the experimental Covid-19 oral antiviral from Merck & Co. and partner Ridgeback Biotherapeutics LP. Researchers plan to study molnupiravir and Omicron soon but think the drug could be effective because it has been found to work against other Covid-19 variants, the …

FDA: Merck COVID pill effective, experts will review safety
3 years ago

FDA: Merck COVID pill effective, experts will review safety

Associated Press  

Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems during pregnancy. Additionally, the FDA flagged a concern that Merck’s drug led to small changes in the coronavirus’ signature spike protein, which it uses to penetrate human cells. …

Merck’s COVID pill shows lower efficacy in updated study
3 years ago

Merck’s COVID pill shows lower efficacy in updated study

Al Jazeera  

Drugmaker says final analysis of trial results showed molnupiravir led to 30 percent reduction in hospitalisations and deaths, compared with about 50 percent in interim study. Drugmaker Merck’s experimental COVID-19 pill is significantly less effective in slashing hospitalisations and deaths than previously reported, the company has said, following the release of a full analysis of trial results. The United States-based …

Merck asks EU drug regulator to authorise its Covid-19 pill
3 years, 1 month ago

Merck asks EU drug regulator to authorise its Covid-19 pill

Hindustan Times  

The European Medicines Agency said it has received a request from Merck to authorise its coronavirus antiviral, the first pill shown to treat Covid-19. In a statement Tuesday, the EU drug regulator said it had started evaluating molnupiravir, made by Merck and Ridgeback Biotherapeutics, and that a decision could be made within weeks on whether it might be cleared. Last …

EU regulator recommends Merck’s COVID-19 pill for emergency use
3 years, 1 month ago

EU regulator recommends Merck’s COVID-19 pill for emergency use

Al Jazeera  

The European Union’s medicines watchdog has advised its member states they can use a potentially groundbreaking COVID-19 antiviral pill in emergency situations triggered by soaring infection rates, ahead of the treatment’s formal approval across the bloc. Molnupiravir, which is produced by Merck and Ridgeback Biotherapeutics, can be given within five days of first symptoms to treat adults who do not …

Pfizer signs deal with UN-backed group to let other companies make its COVID-19 pill
3 years, 1 month ago

Pfizer signs deal with UN-backed group to let other companies make its COVID-19 pill

Daily Mail  

Pfizer Inc has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill. Pictured: People walk by the Pfizer world headquarters in New York, November 9 Generic drug companies will be allowed to produce the pill for use in 95 countries, making up about 53% of the world's population 'It's quite significant that …

Pfizer says COVID-19 pill cut hospital, death risk by 90%
3 years, 1 month ago

Pfizer says COVID-19 pill cut hospital, death risk by 90%

Associated Press  

WASHINGTON — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus. Competitor Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on …

Pfizer says Covid-19 pill is 89% effective in preliminary assessment
3 years, 1 month ago

Pfizer says Covid-19 pill is 89% effective in preliminary assessment

Live Mint  

Pfizer Inc. said a preliminary look at study results indicated that its experimental pill was highly effective at preventing people at high risk of severe Covid-19 from needing hospitalization or dying, the latest encouraging performance for an early virus treatment. The company’s drug cut the risk of hospitalization or death in study subjects with mild to moderate Covid-19 by about …

Pfizer says its COVID-19 pill cuts hospitalisations, death by 89%
3 years, 1 month ago

Pfizer says its COVID-19 pill cuts hospitalisations, death by 89%

Al Jazeera  

Pharmaceutical companies are in a race to manufacture easy-to-use medication against the coronavirus. Pfizer has said its experimental antiviral pill for COVID-19 cuts risk rates of hospitalisation and death by nearly 90 percent, as drugmakers race to manufacture easy-to-use medication against the coronavirus. Of those given Pfizer’s drug within three days of symptom onset 0.8 percent were hospitalised and none …

Britain becomes first country to approve Merck's Covid-19 pill molnupiravir
3 years, 1 month ago

Britain becomes first country to approve Merck's Covid-19 pill molnupiravir

India Today  

Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by U.S.-based Merck & Co Inc and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic. Britain's Medicines and Healthcare products Regulatory Agency recommended the drug, molnupiravir, for use in people with mild to moderate COVID-19 and at …

UK approves Merck's antiviral COVID pill molnupiravir in world first
3 years, 1 month ago

UK approves Merck's antiviral COVID pill molnupiravir in world first

ABC  

Britain has become the first country in the world to approve Merck's potentially game-changing COVID-19 antiviral pill. Key points: US advisers will meet this month to vote on whether molnupiravir should be authorised Australia has already ordered 300,000 courses Merck is expecting to produce 10 million courses by the end of this year The UK's Medicines and Healthcare products Regulatory …

UK authorizes Merck antiviral pill, 1st shown to treat COVID
3 years, 1 month ago

UK authorizes Merck antiviral pill, 1st shown to treat COVID

Associated Press  

LONDON — Britain granted conditional authorization on Thursday to the first pill shown to successfully treat COVID-19 so far. The U.S. Food and Drug Administration announced last month it would convene a panel of independent experts to scrutinize the pill’s safety and effectiveness in late November. Merck announced preliminary results in September showing its drug cut hospitalizations and deaths by …

UK becomes first country to approve Merck's anti-Covid pill molnupiravir
3 years, 1 month ago

UK becomes first country to approve Merck's anti-Covid pill molnupiravir

Hindustan Times  

Britain on Thursday approved the use of Merck's antiviral pill to treat patients suffering from mild to moderate Covid-19, the Medicines and Healthcare products Regulatory Agency announced. Based on the clinical trial data, the drug is most effective when taken during the early stages of infection and the MHRA recommends that it be used within five days of the onset …

Molnupiravir: UK authorizes Merck/Ridgeback Biotherapeutics’ antiviral to treat mild-to-moderate Covid-19
3 years, 1 month ago

Molnupiravir: UK authorizes Merck/Ridgeback Biotherapeutics’ antiviral to treat mild-to-moderate Covid-19

CNN  

CNN — The UK Medicines and Healthcare Products Regulatory Agency said Thursday it had authorized Merck and Ridgeback Biotherapeutics’ oral antiviral, molnupiravir, to treat mild-to-moderate Covid-19 in adults at risk for severe illness. The companies have sought US Food and Drug Administration emergency use authorization for the drug, and the FDA said it will convene its Antimicrobial Drugs Advisory Committee …

Britain becomes the first nation to authorize Merck’s COVID-19 pill
3 years, 1 month ago

Britain becomes the first nation to authorize Merck’s COVID-19 pill

LA Times  

So far Merck’s COVID-19 pill is the only one shown to successfully treat the disease. Britain has granted conditional authorization to Merck’s COVID-19 pill — the only one so far shown to successfully treat the disease — becoming the first nation to OK the treatment, although it was not immediately clear how quickly the drug would be available. Merck and …

UK approves Merck’s antiviral COVID-19 pill in world first move
3 years, 1 month ago

UK approves Merck’s antiviral COVID-19 pill in world first move

Al Jazeera  

Merck’s molnupiravir to be given to recently-infected COVID-19 patients twice a day, for five days. The United Kingdom has become the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by Merck and Ridgeback Biotherapeutics. Merck’s molnupiravir has been closely watched since data last month showed it could halve the chances of dying or …

Merck strikes deal for global access to COVID-19 medication
3 years, 1 month ago

Merck strikes deal for global access to COVID-19 medication

Al Jazeera  

The deal could pave the way for the use of antiviral drug molnupiravir in 105 low- and middle-income countries. The global Medicines Patent Pool, which is backed by the United Nations, said on Wednesday it had signed a voluntary licensing agreement with Merck to facilitate affordable worldwide access for its antiviral medicine molnupiravir. “The interim results for molnupiravir are compelling …

EU medicines watchdog starts review of Merck COVID pill
3 years, 2 months ago

EU medicines watchdog starts review of Merck COVID pill

Al Jazeera  

The treatment is considered a potential game changer in the global fight against the coronavirus. The European Medicines Agency – the European Union’s top medicines watchdog – has started a review of a potentially ground-breaking antiviral pill to treat COVID-19. The company reported earlier this month that the pill cut hospitalisations and deaths by half among patients with early symptoms …

WHO-led program aims to buy antiviral Covid-19 pills for $10
3 years, 2 months ago

WHO-led program aims to buy antiviral Covid-19 pills for $10

CNN  

A World Health Organization-led program to ensure poorer countries get fair access to Covid-19 vaccines, tests and treatments aims to secure antiviral drugs for patients with mild symptoms for as little as $10 per course, a draft document seen by Reuters says. The document, which outlines the goals of the Access to Covid-19 Tools Accelerator until September next year, says …

Merck Covid pill: Asian countries are rushing to buy molnupiravir but poor countries could miss out
3 years, 2 months ago

Merck Covid pill: Asian countries are rushing to buy molnupiravir but poor countries could miss out

CNN  

CNN — During the global scramble to secure vaccines, many countries in Asia-Pacific were slow off the mark. “This is a game changer.” What the Covid pill means for vaccines Vaccines are still the best protection, say experts – after all, they can reduce the risk of a person getting Covid-19 at all. “This drug will be a frontline solution …

Merck seeks first US authorization for Covid-19 tablet
3 years, 2 months ago

Merck seeks first US authorization for Covid-19 tablet

Live Mint  

Merck & Co Inc said on Monday it has applied for US emergency use authorization for its tablet to treat mild-to-moderate patients of COVID-19, putting it on course to become the first oral antiviral medication for the disease. An authorization from the US Food and Drug Administration could help change clinical management of COVID-19 as the pill can be taken …

Discover Related